The discovery of neocentromere activity by maize knobs heralded the field of meiotic drive, in which selfish genetic elements exploit meiotic asymmetry to enhance their propagation. A new study reveals the long-awaited basis of this meiotic drive: cytoskeletal motors enable neocentromeric knobs to achieve favorable meiotic positioning and preferential inheritance.
Female meiosis is inherently asymmetric: only one of four meiotic products is transmitted to the next generation via the oocyte. Selfish genetic elements can exploit this asymmetry to preferentially transmit themselves. The first proposal of such ''meiotic drive'' was a heretical challenge to the well-established orthodoxy of Mendelian equal segregation. This proposal stemmed from curious observations made by Marcus Rhoades in 1942 (Rhoades, 1942) , who found that non-centromeric blocks of satellite-DNA, or ''knobs,'' in maize could transmit themselves more frequently than expected through asymmetric female meiosis, but not symmetric male meiosis. Knobcontaining Abnormal 10 (Ab10) chromosomes could outcompete Normal 10 (N10) chromosomes and sponsor drive of other knob-containing chromosomes that were incapable of driving on their own (Rhoades and Dempsey, 1966) . However, it remained unclear what special property of the Ab10 chromosome was responsible. In this issue of Cell, Dawe et al. (2018) provide a satisfying solution to this long-standing puzzle by identifying a Kinesin-driver (Kindr) multigene family that is genetically linked to the Ab10 knobs. This neofunctionalized kinesin is a microtubule-based motor that localizes to knobs and directly moves them into a favored meiotic position, bypassing the requirement of a canonical centromere or kinetochore for chromosome segregation and achieving preferential transmission.
Drive during female meiosis requires two genetic components: a cis-acting responder locus (in this case, the satellite-DNA of the knobs) and a trans-acting driver (Sandler and Novitski, 1957; Lindholm et al., 2016; McLaughlin and Malik, 2017) . Since only Ab10 knobs are capable of autonomously driving during meiosis, the driver locus had to be genetically linked to the knob on this chromosome. The authors of the new study compared meiotic cells of Ab10-containing and Ab10-deficient maize and revealed that one coding gene-a unique kinesin-14A homolog named Kindr-was only expressed in the Ab10-containing plant (Dawe et al., 2018) . Further analyses revealed seven additional Kindr gene duplicates clustered tandemly in the Ab10 locus (the ''Kindr complex''). Several lines of evidence-the close genetic linkage of the Kindr locus, its exclusive expression in the Ab10 plants, and the loss of drive upon epigenetic silencing of the Kindr genes-provide strong genetic support that the Kindr locus encodes the longsought driver of maize knobs (Dawe et al., 2018) .
How does Kindr achieve meiotic drive of knobs? Marcus Rhoades had discovered that knobs formed ''neocentromeres,'' which are pulled along microtubules toward the meiotic spindle poles despite lacking a canonical kinetochore (Rhoades, 1942; Rhoades and Dempsey, 1966) . Although female gametogenesis in maize results in four cells in a linear tetrad, only the lower cell of the linear tetrad develops into the egg (or megaspore), while the other three cells are eliminated. Rhoades posited a model in which rapid neocentromere movement could lead to an outward orientation of Ab10 chromosomes, resulting in their preferential segregation to the upper and lower cells of the tetrad (and therefore preferential inheritance) relative to knob-lacking chromosomes (Figure 1 ) (Rhoades, 1942; Rhoades and Dempsey, 1966) . Consistent with these remarkably prescient predictions, Dawe et al. (2018) demonstrate that Kindr genes encode functional kinesin proteins that provide rapid motility of knob neocentromeres. Like other kinesin-14 family members, Kindr moves toward the minus-end of microtubules in vitro ( Figure 1A ). Interestingly, despite 94% sequence identity, Kindr can move twice as fast as its closest kinesin-14 homolog; its faster motility may have been selected for in order to ''outrun'' canonical centromeres and move neocentromeric knobs rapidly into the megaspore.
The discovery of the Kindr genes may reveal novel biochemical features of kinesin proteins. Kindr's rapid motility may be the result of an intrinsically faster motor, or Kindr proteins may gain speed and processivity by traveling in a cluster, similar to a kinesin-14 motor in the moss P. patens (Jonsson et al., 2015) . By immunolocalizing Kindr proteins to the Ab10 locus, Dawe et al. confirmed that the repetitive DNA-satellites comprising the knob are indeed Kindr's cargo. Chromokinesins are a class of kinesins that can bind directly to chromosomes via their tail domains. The Kindr tail is quite divergent and may allow it to either directly bind knobs with exquisite specificity or to indirectly dock onto knobs via an adaptor protein.
Meiotic drive is a prime example of intragenomic conflict in which two genetic entities within the same genome have adversarial evolutionary goals. In this case, the transmission advantage of the selfish genetic element Ab10 (and genetically linked Kindr) is in direct conflict with the rest of the maize genome, which suffers lower reproductive fitness in part due to reduced pollen and seed production in Ab10 homozygotes (Higgins et al., 2018) . Due to this lower fitness, it is expected that the maize genome would try to suppress Ab10 meiotic drive. Indeed, Dawe et al. (2018) identify epimutants that influence DNA methylation of the Kindr locus and preclude meiotic drive, as well as pseudo-Kindr genes that produce siRNAs that might target Kindr to combat Kindr expression. Consistent with this cycle of adaptation and counteradaptation, Kindr exhibits signatures of diversifying selection, which may reflect selective pressures either to evade genomic suppression or to direct the meiotic advantage to only the Ab10-linked knobs. Kindr genes have also undergone multiple duplication events; increased gene dosage may be important to ensure preferential segregation of Ab10. The discovery of the Kindr locus will now allow further mechanistic studies to address these exciting possibilities.
Since Marcus Rhoades' first proposal of meiotic drive, this concept has reemerged in many studies of meiosis (Sandler and Novitski, 1957; Lindholm et al., 2016; McLaughlin and Malik, 2017) . Similar to knobs' drive in meiosis II, it has been proposed that centromeric satellite DNA may selfishly drive in meiosis I (Henikoff and Malik, 2002) . Although the traditional focus in studies of meiotic drive has been on the chromosomal responder elements, new studies indicate a perceptible shift in focus onto the cytoskeletal basis of drive. For example, a recent study found that ''driving'' centromeres sense the inherent asymmetry of the spindle during meiosis I in mouse oocytes to preferentially orient themselves (Akera et al., 2017) . The discovery by Dawe et al. (2018) that a cytoskeletal motor actively creates asymmetry during meiosis II in the firstidentified example of meiotic drive (Rhoades, 1942 ) is a satisfying conclusion to the original tale of chromosomal deceit that began more than 75 years ago.
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Matching genetically defined cancer states to drugs that specifically target these states is a principal goal of personalized oncology medicine. In this issue, McMillan et al. show how largescale chemical screening coupled to deep molecular profiling can identify mechanistically diverse druggable vulnerabilities for genetic subtypes of lung cancers.
Cancer research and treatment have greatly benefited from advances in DNA sequencing technologies, which have facilitated the discovery of genetic alterations driving tumorigenesis. Groundbreaking medicines have been developed that target the protein products of some mutated oncogenes-in particular, kinases (Huang et al., 2014) . Many other genetically defined cancers, however, still lack targeted therapies, and some tumor types, including lung cancer, are so heavily mutated that it can be difficult to discern their oncogenic dependencies from DNA sequencing alone, further complicating the path toward therapeutic advances. While molecular biology methods, such as RNA interference and genome editing, have been employed with good success to discover proteins required for the viability of specific subtypes of cancers (Wang et al., 2017) , these approaches often identify proteins that are challenging to target with small-molecule or macromolecular drugs (e.g., transcription factors). Such methods are also weighted toward loss-of-function (LoF) outcomes and therefore less likely to uncover therapeutic opportunities for gain-of-function (GoF) pharmacology.
Small-molecule screening can both complement and address the limitations of genetic approaches by providing a means to directly discover druggable vulnerabilities that reflect not only LoF, but also GoF, and even neo-functional mechanisms of action (Austin et al., 1994; Lu et al., 2014) (Figure 1 ). Key to the success of targeted small-molecule therapies, however, is pinpointing specific tumor types that show maximal drug sensitivity. In this issue of Cell, McMillan et al. (2018) describe a multi-faceted, chemistrycentric screening strategy to identify druggable dependencies associated with specific genetic alterations in a heterogeneous collection of non-smallcell lung cancer (NSCLC) models. This approach began with the rigorous molecular characterization (DNA, mRNA, protein, and metabolite) of a panel of 96 NSCLC cell lines and 4 immortalized human bronchial epithelial cell lines followed by computational clustering to create an ensemble of 15 distinct phenotypic groups, from which representative lines were screened for growth inhibition against a diversity-oriented 200,000 compound library. It is noteworthy that less than 1% of the compounds in the chemical library have known mechanisms of action, distinguishing this study from other cancer cell line screening initiatives that have utilized smaller libraries of chemical probes with established targets/mechanisms (Basu et al., 2013; Iorio et al., 2016; Seashore-Ludlow et al., 2015) , positioning it to discover previously ''undrugged'' targets and pathways. The authors validated their screening and data analysis approach by showing that it properly predicted the sensitivity of tumors with high ALK expression to the ALK inhibitor crizotinib and also tumors with EGFR mutation/amplifications to the EGFR inhibitor erlotinib.
In total, the authors confidently linked an impressive 171 compounds to genomic features of lung cancer that span a broad array of potential druggable vulnerabilities. One such association that constituted a GoF pharmacological outcome was the selective sensitivity to glucocorticoid receptor agonists displayed by NSCLC cells harboring mutations in NOTCH2, an implicated tumor suppressor. These cancer cells were found to have reduced Notch signaling and elevated basal expression levels of the glucocorticoid receptor NR3C1, priming cells to respond to glucocorticoids and undergo subsequent cell-cycle
